69 related articles for article (PubMed ID: 34927183)
21. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
mBio; 2021 May; 12(3):. PubMed ID: 33975938
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites.
Lechuga GC; Souza-Silva F; Sacramento CQ; Trugilho MRO; Valente RH; Napoleão-Pêgo P; Dias SSG; Fintelman-Rodrigues N; Temerozo JR; Carels N; Alves CR; Pereira MCS; Provance DW; Souza TML; De-Simone SG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445741
[TBL] [Abstract][Full Text] [Related]
23.
Rout J; Swain BC; Tripathy U
J Biomol Struct Dyn; 2022 Feb; 40(2):860-874. PubMed ID: 32938313
[TBL] [Abstract][Full Text] [Related]
24. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
25. Development of a new nano arginase HPLC capillary column for the fast screening of arginase inhibitors and evaluation of their binding affinity.
André C; Guillaume YC
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122751. PubMed ID: 33991957
[TBL] [Abstract][Full Text] [Related]
26. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
27. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin fragment F(ab')
Pan X; Zhou P; Fan T; Wu Y; Zhang J; Shi X; Shang W; Fang L; Jiang X; Shi J; Sun Y; Zhao S; Gong R; Chen Z; Xiao G
Antiviral Res; 2020 Oct; 182():104868. PubMed ID: 32659292
[TBL] [Abstract][Full Text] [Related]
29. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
30. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation.
Jawad B; Adhikari P; Podgornik R; Ching WY
J Chem Inf Model; 2021 Sep; 61(9):4425-4441. PubMed ID: 34428371
[TBL] [Abstract][Full Text] [Related]
31. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
Jeong H; Choi YM; Seo H; Kim BJ
Front Immunol; 2021; 12():637654. PubMed ID: 33732258
[TBL] [Abstract][Full Text] [Related]
32. Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study.
Aatif M; Muteeb G; Alsultan A; Alshoaibi A; Khelif BY
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922914
[TBL] [Abstract][Full Text] [Related]
33. A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
Wang X; Yang C; Sun Y; Sui X; Zhu T; Wang Q; Wang S; Yang J; Yang W; Liu F; Zhang M; Wang Y; Luo Y
Environ Int; 2021 Feb; 147():106361. PubMed ID: 33401173
[TBL] [Abstract][Full Text] [Related]
34. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.
Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F
Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386
[TBL] [Abstract][Full Text] [Related]
35. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.
Chen WH; Hotez PJ; Bottazzi ME
Hum Vaccin Immunother; 2020 Jun; 16(6):1239-1242. PubMed ID: 32298218
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display.
Norman A; Franck C; Christie M; Hawkins PME; Patel K; Ashhurst AS; Aggarwal A; Low JKK; Siddiquee R; Ashley CL; Steain M; Triccas JA; Turville S; Mackay JP; Passioura T; Payne RJ
ACS Cent Sci; 2021 Jun; 7(6):1001-1008. PubMed ID: 34230894
[TBL] [Abstract][Full Text] [Related]
37. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
[TBL] [Abstract][Full Text] [Related]
38. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
Front Immunol; 2021; 12():793953. PubMed ID: 34899762
[TBL] [Abstract][Full Text] [Related]
39. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
40. Analytical characterization of the SARS-CoV-2 EURM-017 reference material.
Freeman J; Olson K; Conklin J; Shalhoub V; Johnson BA; Bopp NE; Fernandez D; Menachery VD; Aguilar PV
Clin Biochem; 2022 Mar; 101():19-25. PubMed ID: 34933006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
